Inactive Instrument

Highlights CM Life Sciences III Inc. Nasdaq

Equities

CM Life Sciences III : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	21/21/21	PU
Drug Firm EQRx to Make Nasdaq Debut Monday After Merger Deal With Blank Check Company	18/21/18	MT
EQRx, Inc. completed the acquisition of CM Life Sciences III Inc. from CMLS Holdings III LLC and others in a reverse merger transaction.	17/21/17	CI
EQRx and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination	02/21/02	BU
EQRx, Inc. and CM Life Sciences III Announce Effectiveness of Form S-4 Registration Statement and Stockholder Meeting Details to Vote on Proposed Business Combination	02/21/02	CI
CM LIFE SCIENCES III INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	24/21/24	AQ
CM Life Sciences III : EQRx to Collaborate With England's National Health Service Over Cheaper Cancer Medicines	20/21/20	MT
CM Life Sciences III : EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III	06/21/06	BU
EQRx, Inc. executed a non-binding Letter of intent to acquire CM Life Sciences III Inc. from CMLS Holdings III LLC and others for $4.2 billion in a reverse merger transaction.	06/21/06	CI
CM LIFE SCIENCES III INC. : Other Events (form 8-K)	03/21/03	AQ
CM Life Sciences III Inc. has completed an IPO in the amount of $480 million.	07/21/07	CI
CM Life Sciences III Inc. has filed an IPO in the amount of $400 million.	24/21/24	CI

No results for this search